SecBot SecBot
144 ·Filed Oct 19, 2026

DNA

Ginkgo Bioworks Holdings, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed7d 18h ago SEC0001959173-26-007422
Form 144 — notice of proposed sale of securities
Actionable Insight • Neutral

This is a routine tax-withholding sale by an officer following a vesting event. No signal of insider concern. Monitor for any larger discretionary insider sales in future filings.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+5d
DNA ▼ -0.50% at T+5d
NEUTRAL call -0.50% · α vs SPY -0.35% · entry $10.07 → $10.02
Next anchor: T+20d in 20d
Entry = T+0 close
Oct 19, 2026
via day close
T+1d
-2.09%
call -2.09% · α -2.42%
$9.86
settled 7d ago
T+5d
-0.50%
call -0.50% · α -0.35%
$10.02
settled yesterday
T+20d
Pending
in 20d
T+60d
Pending
in 3mo

Price Chart

Loading chart...

Executive Summary

Steven P. Coen, an officer of Ginkgo Bioworks, filed a Form 144 notice of intent to sell 766 Class A shares valued at approximately $7,769. The shares were acquired via restricted stock vesting on October 16, 2026, and the sale is to cover a tax obligation from the settlement of a vested equity award. This is a routine, small insider sale tied to tax withholding, not a discretionary portfolio decision.

Key Facts

  • Officer Steven P. Coen filed Form 144 to sell 766 Class A shares.
  • Estimated sale value: $7,769.23 (based on $10.14/share reference price).
  • Shares acquired via restricted stock vesting on October 16, 2026.
  • Sale is to cover tax obligation from vested equity award settlement.
  • Sale represents a tiny fraction of the company's 553.8 million shares outstanding.

Financial Impact

Approximately $7,769 in shares sold, immaterial relative to market cap.

dilution

Risk Factors

  • None from this filing; the sale is mandatory tax-related, not discretionary.

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001959173-26-007422
Document: 0001959173-26-007422-index.html0001959173-26-007422
Document: 0001959173-26-007422.txt0001959173-26-007422
5 reports for DNA
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for DNA — sortable, filterable
TypeNow
Oct 21, 2026
5d ago
Insider Cluster
NEUTRAL ★ 2/10
$9.71awaiting T+60—$10.36 (+6.69%)
Oct 19, 2026
7d ago
144
NEUTRAL ★ 2/10
$10.07awaiting T+60—$10.36 (+2.88%)
Sep 15, 2026
5w ago
144
NEUTRAL ★ 2/10
$6.99awaiting T+60—$10.36 (+48.21%)
Apr 9, 2026
28w ago
Insider Cluster
BEARISH ★ 6/10
$6.43 $10.11▼ −57.23%▼ −46.45%$10.36 (−61.12%)
Apr 9, 2026
28w ago
Insider Cluster
BEARISH ★ 6/10
$6.43 $10.11▼ −57.23%▼ −46.45%$10.36 (−61.12%)
Showing 5 of 5

US Market Status

Market Open — Closes in 5h 9m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 19, 2026